StockNews.com Initiates Coverage on Palatin Technologies (NYSE:PTN)

StockNews.com started coverage on shares of Palatin Technologies (NYSE:PTN) in a research report report published on Saturday morning. The firm issued a sell rating on the stock.

Palatin Technologies Price Performance

Shares of NYSE:PTN opened at $0.21 on Friday. Palatin Technologies has a twelve month low of $0.16 and a twelve month high of $2.48. The stock has a market cap of $5.46 million, a price-to-earnings ratio of -0.14 and a beta of 0.89.

Palatin Technologies Company Profile

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.